When sourcing high-purity laboratory reagents, biomedical investigators can buy NAD+ peptide online through PX1 Research to ensure precise analytical verification, rapid domestic dispatch, and strict lot-to-lot consistency. Supplied strictly as a research-grade coenzyme for in vitro assays and preclinical cellular models, our oxidized nicotinamide adenine dinucleotide facilitates reproducible investigation into metabolic biochemistry, enzymatic signaling, and mitochondrial dynamics without the confounding variables of unverified commercial reagents.
When sourcing high-purity laboratory reagents, biomedical investigators can buy NAD+ peptide online through PX1 Research to ensure precise analytical verification, rapid domestic dispatch, and strict lot-to-lot consistency. Supplied strictly as a research-grade coenzyme for in vitro assays and preclinical cellular models, our oxidized nicotinamide adenine dinucleotide facilitates reproducible investigation into metabolic biochemistry, enzymatic signaling, and mitochondrial dynamics without the confounding variables of unverified commercial reagents.
Biomedical research facilities seeking to buy NAD+ peptide online require fully characterized analytical reagents that guarantee experimental reproducibility. Nicotinamide Adenine Dinucleotide (NAD+) is a central metabolic coenzyme responsible for transferring electrons in cellular redox reactions and serving as an essential substrate for regulatory enzymes. In cell culture systems, cell-free enzymatic assays, and tissue explant models, the integrity of the coenzyme substrate directly dictates the validity of downstream enzymatic and metabolic observations.
PX1 Research supplies reference-grade NAD+ optimized for controlled laboratory investigations. Every lot produced for our research catalog undergoes rigorous quality control protocols to ensure high chemical purity, minimal moisture retention, and zero heavy metal contamination. By purchasing directly through our US-based manufacturing and logistics pipeline, academic institutions, biotechnology enterprises, and clinical laboratories eliminate the supply chain risks associated with overseas distributors or unverified synthesis houses.
Although commonly referred to alongside signaling peptides in metabolic biochemistry catalogs, oxidized Nicotinamide Adenine Dinucleotide (NAD+, CAS 53-84-9) is chemically classified as a dinucleotide coenzyme. The molecule consists of two phosphate-linked nucleotides: one containing an adenine nucleobase and the other containing a nicotinamide ring. The molecular formula of the free acid form is C21H27N7O14P2, with a formula weight of approximately 663.43 g/mol.
The primary biochemical utility of NAD+ stems from its reversible redox center located at the nicotinamide ring. During metabolic reactions, the nicotinamide moiety accepts two electrons and one proton, reducing to NADH. This equilibrium (NAD+/NADH balance) serves as a fundamental read-out in cellular bioenergetics research. In addition to its role as a hydride acceptor in glycolysis, the citric acid cycle, and beta-oxidation, the oxidized NAD+ pool functions as a rate-limiting substrate for non-redox signaling enzymes, including sirtuins (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38/CD157).
Preclinical investigations routinely utilize exogenously supplied NAD+ to evaluate cellular responses under conditions of metabolic stress, oxidative load, and accelerated cellular senescence. In cell culture models, maintaining physiological or elevated extracellular NAD+ concentrations allows researchers to observe changes in sirtuin-dependent protein deacetylase activity. In vitro data indicate that elevated sirtuin signaling modulates downstream transcriptomic pathways associated with mitochondrial biogenesis, nuclear-mitochondrial communication, and chromatin remodeling.
Furthermore, animal models evaluating age-associated metabolic decline frequently examine how fluctuating tissue levels of NAD+ alter mitochondrial respiratory chain efficiency. Rodent studies suggest that restoring intracellular NAD+ availability via direct supplementation or precursor delivery supports oxidative phosphorylation capacity, enhances ATP synthesis rate, and attenuates nuclear DNA damage responses mediated by PARP consumption. Researchers exploring these pathways can access technical literature and mechanism deep-dives through the PX1 Research Library.
Cellular models of ischemia-reperfusion injury and neurodegenerative stress also utilize high-purity NAD+ to assess cell survival kinetics. In vitro neuronal assays demonstrate that maintaining adequate NAD+ pools preserves axonal integrity following mechanical or chemical insult, offering a crucial baseline for evaluating therapeutic targets in neuroprotection and metabolic signaling.
To ensure that researchers receiving reagents from PX1 Research acquire precise materials, every batch of NAD+ coenzyme reagent undergoes exhaustive third-party analytical testing. Industrial synthesis or purification of dinucleotide compounds can yield unwanted impurities, including degraded mononucleotide fragments, residual synthesis solvents, and structural isomers that skew experimental readings in spectrophotometric and enzymatic assays.
We verify chemical identity and quantitative purity using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) paired with Electrospray Ionization Mass Spectrometry (ESI-MS). RP-HPLC separates the parent compound from trace breakdown products, ensuring a Chromatographic Purity rating typically exceeding 98%. Simultaneously, mass spectrometry confirms the exact molecular mass and fragmentation pattern, guaranteeing the absence of misidentified coenzymes or degraded intermediates. Investigators can access third-party Certificate of Analysis (COA) documents directly per lot prior to assay setup.
For researchers conducting delicate cell culture, organoid, or ex vivo tissue studies, endotoxin contamination presents a major confounding variable. Bacterial lipopolysaccharides (LPS) induce robust inflammatory signaling cascades through Toll-like Receptor 4 (TLR4), completely invalidating downstream immunological, metabolic, or apoptotic data.
PX1 Research mitigates this risk by subjecting all research compounds to quantitative Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing. Our rigorous standards mandate endotoxin limits well below industry baselines (<0.01 EU/mg), ensuring that in vitro cellular models treated with our reagents react exclusively to the target molecule rather than pyrogenic contaminants. Furthermore, manufacturing occurs within ISO-certified, GMP-compliant facilities adhering to strict environmental controls.
Nicotinamide Adenine Dinucleotide is delivered as a stable, lyophilized powder to preserve chemical integrity during transit. Upon arrival, the unconstituted lyophilate should be stored in a dry, dark environment at -20°C or -80°C to prevent hydrolysis of the phosphoanhydride bonds.
For laboratory reconstitution, researchers should utilize sterile, nuclease-free water or appropriate physiological buffers such as phosphate-buffered saline (PBS). Because aqueous solutions of NAD+ undergo gradual degradation over time—accelerated by elevated temperatures and neutral-to-alkaline pH—reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes and stored at -80°C. Avoiding repeated freeze-thaw cycles is essential to maintain uniform substrate concentrations across long-term longitudinal studies.
In metabolic research, investigators frequently compare the kinetics of primary redox coenzymes against target-specific mitochondrial signaling peptides. While NAD+ acts directly as a global dinucleotide cofactor and enzymatic substrate, mitochondrial-derived peptides work through distinct receptor interaction mechanisms to modulate organellar function.
For example, researchers studying energy homeostasis and mitochondrial efficiency often compare NAD+ dynamics to MOTS-c peptide research, a mitochondrial-derived peptide that regulates nuclear gene expression during metabolic stress. Similarly, compounds like SS-31 target research focus on cardiolipin binding within the inner mitochondrial membrane to reduce reactive oxygen species (ROS) production, whereas NAD+ modulates the broader redox environment and enzymatic deacetylase activity. For large-scale screening protocols involving these complementary research targets, laboratories can explore customized bulk options via our wholesale portal.
When evaluating where to buy NAD+ peptide online, principal investigators must audit supplier credentials to prevent experimental drift caused by variable reagent purity. PX1 Research operates domestic manufacturing and fulfillment facilities located in California and Arizona, providing immediate dispatch and transparent batch tracking.
Key operational standards provided by PX1 Research include:
- Domestic synthesis and packaging within ISO 17025 accredited and GMP-compliant environments.
- Complete lot traceability from raw material synthesis to final analytical packaging.
- Fully accessible, third-party verified COAs featuring full RP-HPLC chromatograms and mass spectra.
- Same-day dispatch on standard business days (Monday through Friday) to minimize supply chain latency for active laboratory projects.
Integrating high-purity NAD+ into experimental protocols requires precise consideration of baseline spectrophotometric properties. NAD+ absorbs ultraviolet light with a characteristic peak at 260 nm, whereas its reduced counterpart (NADH) exhibits dual absorption peaks at 260 nm and 340 nm. Measuring the optical density ratio at 340 nm provides a standard fluorometric or spectrophotometric readout for enzymatic assays quantifying NAD+/NADH interconversion.
When designing cell-based supplementation studies, researchers must also account for extracellular enzyme activity. Cell-surface ectoenzymes such as CD38 rapidly cleave extracellular NAD+ into nicotinamide and cyclic ADP-ribose. Investigators testing intracellular target activation may need to incorporate selective ectoenzyme inhibitors into their culture media to ensure that intact coenzymes or expected breakdown products reach target intracellular compartments efficiently.
How is the purity of NAD+ verified at PX1 Research?
Every lot of NAD+ undergoes independent third-party analytical testing, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chemical purity (>98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm molecular identity and structure.
What is the recommended storage temperature for lyophilized NAD+?
Unreconstituted, lyophilized NAD+ powder should be stored at -20°C for short-to-medium storage, or -80°C for long-term preservation, away from direct light and moisture to prevent degradation.
Is NAD+ classified as a peptide or a coenzyme?
Biochemically, NAD+ is a dinucleotide coenzyme consisting of two phosphate-linked nucleotides (adenine and nicotinamide). It is frequently cataloged alongside research peptides due to its overlapping applications in metabolic and cellular signaling research.
What solvent should be used to reconstitute NAD+ for laboratory use?
NAD+ is readily soluble in sterile, nuclease-free water or standard physiological buffers like PBS. Stock solutions should be aliquoted and frozen at -80°C to prevent hydrolytic breakdown.
Does PX1 Research provide a lot-specific Certificate of Analysis (COA)?
Yes. Every shipment of NAD+ corresponds to a specific batch number whose full analytical COA—including HPLC chromatograms, mass spectra, and endotoxin levels—is accessible directly through our site.
What are the endotoxin limits for PX1 Research coenzymes and peptides?
All research compounds undergo LAL endotoxin testing and must meet strict purity thresholds (<0.01 EU/mg) to prevent non-specific pyrogenic reactions in cell culture or preclinical models.
How quickly are orders processed and shipped?
Orders placed Monday through Friday before our daily cutoff time ship same-day directly from our facilities in California and Arizona.
Can NAD+ be purchased for human consumption or therapeutic use?
No. All products offered by PX1 Research, including NAD+, are strictly intended for in vitro, cell culture, and laboratory research use only. They are not for human, clinical, or therapeutic applications.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.